-
Making Collaboration More Common for Rare Cancers
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Medicaid: A Partial Safety Net
Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.
by Sharon Tregaskis
-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Facts and Stats
Fifty Years of Growing SurvivorshipMore people in the U.S. are alive after being diagnosed with cancer than ever before.
by Eric Fitzsimmons
-
Policy Matters
Cancer Research: The Key to Tomorrow’s CuresThe AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.
by David A. Tuveson, MD, PhD
-
From the Editor-in-Chief
Improving Clinical TrialsThe fast pace of drug discovery should be matched by modernized clinical trials for wider access.
by William G. Nelson, MD, PhD
-
Policy Matters
The FDA Takes Steps to Curb Tobacco UseThe federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.
by Nicholas Warren, PhD
-
Get Involved
Cooking Up SupportJohn Hanley's ChemoCookery Twitter account has become a place to share meal ideas and have conversations about cooking, cancer and the crossover between them.
by Bradley Jones
-
Oncology Takes on Cannabis
People take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.
by Kate Yandell
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles